DE69710574D1 - Diclofenac/gamma-cyclodextrin klathrat komponente - Google Patents

Diclofenac/gamma-cyclodextrin klathrat komponente

Info

Publication number
DE69710574D1
DE69710574D1 DE69710574T DE69710574T DE69710574D1 DE 69710574 D1 DE69710574 D1 DE 69710574D1 DE 69710574 T DE69710574 T DE 69710574T DE 69710574 T DE69710574 T DE 69710574T DE 69710574 D1 DE69710574 D1 DE 69710574D1
Authority
DE
Germany
Prior art keywords
diclofenac
pct
gamma
date
cyclodextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69710574T
Other languages
English (en)
Inventor
Wilfried Fischer
Anna Sendl-Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Application granted granted Critical
Publication of DE69710574D1 publication Critical patent/DE69710574D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69710574T 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin klathrat komponente Expired - Lifetime DE69710574D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9600758A HUP9600758A2 (en) 1996-03-27 1996-03-27 Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
PCT/EP1997/001595 WO1997035568A2 (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds

Publications (1)

Publication Number Publication Date
DE69710574D1 true DE69710574D1 (de) 2002-03-28

Family

ID=89993834

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69710574T Expired - Lifetime DE69710574D1 (de) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin klathrat komponente

Country Status (13)

Country Link
US (1) US6071964A (de)
EP (1) EP0893994B1 (de)
JP (1) JP2000507258A (de)
CN (1) CN1217658A (de)
AT (1) ATE213410T1 (de)
AU (1) AU713902B2 (de)
BR (1) BR9708280A (de)
CA (1) CA2250009A1 (de)
DE (1) DE69710574D1 (de)
HU (1) HUP9600758A2 (de)
PL (1) PL329036A1 (de)
WO (1) WO1997035568A2 (de)
ZA (1) ZA972707B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2379854B (en) * 2001-09-19 2006-04-19 Walcom Animal Science Dairy cow feed and the use thereof
AU2002366588A1 (en) * 2001-12-13 2003-06-23 Council Of Scientific And Industrial Research Bioavailability enhancing activity of zingiber officinale linn and its extracts/fractions thereof
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
CN1232539C (zh) * 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
KR20170123724A (ko) 2006-03-28 2017-11-08 자블린 파머슈티칼스 인코포레이티드 저 투여량의 디클로페낙 및 베타-사이클로덱스트린 제형
KR20090010953A (ko) * 2006-03-28 2009-01-30 자블린 파머슈티칼스 인코포레이티드 저 복용량의 비-스테로이드성 항염증성 약물 및 베타-사이클로덱스트린 제형
JP2009196922A (ja) * 2008-02-21 2009-09-03 Glovia:Kk 徐放性フェルラ酸製剤
WO2009108828A2 (en) * 2008-02-27 2009-09-03 Dr. Reddy's Laboratories Ltd. Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
EP2422818A3 (de) * 2010-08-27 2013-01-16 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Verfahren zur Herstellung eines Diclofenac-Cyclodextrin Konjugates

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5984821A (ja) * 1982-11-04 1984-05-16 Teikoku Chem Ind Corp Ltd 徐溶化組成物
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1247529B (it) * 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
EP1004318A3 (de) * 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Zyklodextrin-zusammensetzung
DE4207922A1 (de) * 1992-03-13 1993-09-23 Pharmatech Gmbh Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung
WO1994028936A1 (en) * 1993-06-08 1994-12-22 Ciba-Geigy Ag Process for the preparation of an oral solid dosage form containing diclofenac
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
ZA972707B (en) 1997-10-22
JP2000507258A (ja) 2000-06-13
BR9708280A (pt) 1999-08-03
ATE213410T1 (de) 2002-03-15
HUP9600758A2 (en) 1998-03-02
WO1997035568A2 (en) 1997-10-02
CN1217658A (zh) 1999-05-26
AU713902B2 (en) 1999-12-16
HU9600758D0 (en) 1996-05-28
CA2250009A1 (en) 1997-10-02
PL329036A1 (en) 1999-03-01
WO1997035568A3 (en) 1997-12-04
EP0893994B1 (de) 2002-02-20
EP0893994A2 (de) 1999-02-03
AU2382997A (en) 1997-10-17
US6071964A (en) 2000-06-06

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
BG105459A (en) Pharmaceutical moxifloxacin preparation
SE9401728D0 (sv) New compounds II
BR9509975A (pt) Formulação farmacêutica
DE69710574D1 (de) Diclofenac/gamma-cyclodextrin klathrat komponente
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
DE69330601D1 (de) Serotoninergische ergolin derivate
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
NO20004545D0 (no) FremgangsmÕte for fremstilling av (R)-<alfa>-(2,3- dimetoksyfenyl)-1-[2-(4-fluorofenyl)etyl]-4-piperidinmetanol
BG106151A (en) Pharmaceutical complex
HUP9702448A2 (hu) Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény
NO941084D0 (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
DE69910787D1 (de) Neuartige, pharmazeutisch aktive verbindung
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
EA200401617A1 (ru) Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера
BR9712628A (pt) Derivados de 8(9)-deidroestradiol
ES2093280T3 (es) Derivados de leucotrieno-b 4?, procedimiento de obtencion y farmacos.
RU93004708A (ru) Производные замещенного пирролидина и их терапевтически приемлемые соли, способ их получения и фармацевтическая композиция

Legal Events

Date Code Title Description
8332 No legal effect for de